Assignee
JIANGSU HENGRUI MEDICINE CO
CN·119 granted patents·92 pending applications·143 citations·filing 2008–2025
Top patents by PatentIndex Score
211 records- 0194US10905743B2Interleukin 15 protein complexJIANGSU HENGRUI MEDICINE CO·Filed 2015·Granted Feb 2, 2021·9 cites·10 claims
- 0292US12202891B2Antibody capable of binding to thymic stromal lymphopoietin and use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2024·Granted Jan 21, 2025·2 cites·9 claims
- 0392US10633375B2Oxopicolinamide derivative, preparation method therefor and pharmaceutical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2017·Granted Apr 28, 2020·6 cites·21 claims
- 0491US11717559B2Interleukin 15 protein complex and use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2020·Granted Aug 8, 2023·2 cites·15 claims
- 0590US12258394B2IL-5 antibody, antigen binding fragment thereof, and medical application thereforJIANGSU HENGRUI MEDICINE CO·Filed 2022·Granted Mar 25, 2025·1 cites·13 claims
- 0690US9527851B2Pyrrole six-membered heteroaryl ring derivative, preparation method thereof, and medicinal uses thereofJIANGSU HENGRUI MEDICINE CO·Filed 2012·Granted Dec 27, 2016·17 cites·21 claims
- 0789US10160759B2Hydroxyethyl sulfonate of cyclin-dependent protein kinase inhibitor, crystalline form thereof and preparation method thereforJIANGSU HENGRUI MEDICINE CO·Filed 2018·Granted Dec 25, 2018·4 cites·17 claims
- 0889US10023577B2Crystalline form of JAK kinase inhibitor bisulfate and a preparation method thereofJIANGSU HENGRUI MEDICINE CO·Filed 2015·Granted Jul 17, 2018·6 cites·19 claims
- 0988US10428074B2Pyrrole heteroaryl ring derivative and method of use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2018·Granted Oct 1, 2019·6 cites·23 claims
- 1085US10786507B2Pharmaceutical composition containing JAK kinase inhibitor or pharmaceutically acceptable salt thereofJIANGSU HENGRUI MEDICINE CO·Filed 2017·Granted Sep 29, 2020·11 cites·12 claims
- 1185US9422300B2Bisulfate of janus kinase (JAK) inhibitor and preparation method thereforJIANGSU HENGRUI MEDICINE CO·Filed 2014·Granted Aug 23, 2016·9 cites·9 claims
- 1284US11274142B2Fusion protein containing TGF-β receptor and medicinal uses thereofJIANGSU HENGRUI MEDICINE CO·Filed 2018·Granted Mar 15, 2022·3 cites·16 claims
- 1384US10709699B2Pyridone derivative pharmaceutical composition and preparation method thereofJIANGSU HENGRUI MEDICINE CO·Filed 2017·Granted Jul 14, 2020·5 cites·17 claims
- 1484US10323037B2Aminopyridazinone compounds as protein kinase inhibitorsJIANGSU HENGRUI MEDICINE CO·Filed 2018·Granted Jun 18, 2019·4 cites·31 claims
- 1583US10610529B2Trabectedin-inclusive injectable pharmaceutical composition for gastrointestinal external use and a method for manufacturing the sameJIANGSU HENGRUI MEDICINE CO·Filed 2017·Granted Apr 7, 2020·2 cites·18 claims
- 1683US10150770B2Crystal form of bisulfate of JAK inhibitor and preparation method thereforJIANGSU HENGRUI MEDICINE CO·Filed 2015·Granted Dec 11, 2018·6 cites·17 claims
- 1782US10906905B2Five-membered heteroaryl ring bridged ring derivative, preparation method therefor and medical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2017·Granted Feb 2, 2021·2 cites·20 claims
- 1881US12428478B2Anti-Claudin 18.2 antibody and application thereofJIANGSU HENGRUI MEDICINE CO·Filed 2020·Granted Sep 30, 2025·1 cites·17 claims
- 1981US11359021B2PD-L1 antibody, antigen-binding fragment thereof, and pharmaceutical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2019·Granted Jun 14, 2022·2 cites·20 claims
- 2081US10759787B2Benzofuran derivative, preparation method thereof and use thereof in medicineJIANGSU HENGRUI MEDICINE CO·Filed 2016·Granted Sep 1, 2020·2 cites·23 claims
- 2181US10442793B2Oxa spiro derivative, preparation method therefor, and applications thereof in medicinesJIANGSU HENGRUI MEDICINE CO·Filed 2016·Granted Oct 15, 2019·2 cites·24 claims
- 2280US11111249B2Heteroaryl-pyrazole derivative, and preparation method therefor and medical application thereofJIANGSU HENGRUI MEDICINE CO·Filed 2018·Granted Sep 7, 2021·3 cites·15 claims
- 2380US8367710B2Bicyclo-substituted pyrazolon azo derivatives, preparation process and pharmaceutical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2009·Granted Feb 5, 2013·3 cites·25 claims
- 2479US11014914B2Opioid receptor (MOR) agonist salt, fumarate salt crystal form I thereof and preparation method thereofJIANGSU HENGRUI MEDICINE CO·Filed 2018·Granted May 25, 2021·1 cites·11 claims
- 2579US10449250B2Anti-sclerostin antibody, antigen binding fragment and medical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2016·Granted Oct 22, 2019·2 cites·20 claims
- 2679US2026022166A1Antibody capable of binding to thymic stromal lymphopoietin and use therofJIANGSU HENGRUI MEDICINE CO·Filed 2025·Application pending·0 cites
- 2778US11512055B2Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (RORγ) and pharmaceutical uses thereofJIANGSU HENGRUI MEDICINE CO·Filed 2019·Granted Nov 29, 2022·1 cites·2 claims
- 2878US11365247B2IL-5 antibody, antigen binding fragment thereof, and medical application thereforJIANGSU HENGRUI MEDICINE CO·Filed 2018·Granted Jun 21, 2022·1 cites·12 claims
- 2978US11117898B2Pyrazolo-heteroaryl derivative, preparation method and medical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2017·Granted Sep 14, 2021·3 cites·23 claims
- 3077US11273205B2IL-15 protein complex pharmaceutical compositionJIANGSU HENGRUI MEDICINE CO·Filed 2018·Granted Mar 15, 2022·1 cites·14 claims
- 3177US10358424B2Sodium salt of uric acid transporter inhibitor and crystalline form thereofJIANGSU HENGRUI MEDICINE CO·Filed 2018·Granted Jul 23, 2019·1 cites·6 claims
- 3276US9309226B2Crystalline form I of tyrosine kinase inhibitor dimaleate and preparation methods thereofJIANGSU HENGRUI MEDICINE CO·Filed 2013·Granted Apr 12, 2016·3 cites·14 claims
- 3376US8362256B2Salts of N-[4-(1-cyanocyclopentyl)phenyl]-2-(4-pyridylmethyl)amino-3-pyridinecarboxamideJIANGSU HENGRUI MEDICINE CO·Filed 2009·Granted Jan 29, 2013·3 cites·4 claims
- 3475US10889569B2Condensed ring group azacyclobutyl triazole derivative, preparation method therefor and use thereof in medicineJIANGSU HENGRUI MEDICINE CO·Filed 2017·Granted Jan 12, 2021·1 cites·20 claims
- 3575US10626116B2Crystalline form of BTK kinase inhibitor and preparation method thereofJIANGSU HENGRUI MEDICINE CO·Filed 2016·Granted Apr 21, 2020·2 cites·11 claims
- 3674US10722469B2Method for preparing pharmaceutical composition comprising quinoline derivative or salt thereofJIANGSU HENGRUI MEDICINE CO·Filed 2017·Granted Jul 28, 2020·1 cites·4 claims
- 3773US12258405B2CD3 antibody and pharmaceutical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2019·Granted Mar 25, 2025·1 cites·14 claims
- 3873US11535633B2Fused tricyclic heterocycle compounds and therapeutic uses thereofJIANGSU HENGRUI MEDICINE CO·Filed 2019·Granted Dec 27, 2022·2 cites·33 claims
- 3973US11345753B2TIM-3 antibody, antigen binding fragment thereof, and medicinal uses thereofJIANGSU HENGRUI MEDICINE CO·Filed 2018·Granted May 31, 2022·1 cites·18 claims
- 4073US10364234B2Pyridinecarboxamide derivatives, preparation method thereof and pharmaceutical uses thereofJIANGSU HENGRUI MEDICINE CO·Filed 2015·Granted Jul 30, 2019·1 cites·16 claims
- 4171US10022365B2Liposome of irinotecan or irinotecan hydrochloride and preparation method thereofJIANGSU HENGRUI MEDICINE CO·Filed 2017·Granted Jul 17, 2018·3 cites·23 claims
- 4270US12187684B2Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (RORγ) and pharmaceutical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2022·Granted Jan 7, 2025·0 cites·18 claims
- 4370US11312705B2Heteroaryl[4,3-C]pyrimidine-5-amine derivative, preparation method therefor, and medical uses thereofJIANGSU HENGRUI MEDICINE CO·Filed 2018·Granted Apr 26, 2022·1 cites·16 claims
- 4469US11981733B2LAG-3 antibody, antigen-binding fragment thereof, and pharmaceutical application thereofJIANGSU HENGRUI MEDICINE CO·Filed 2021·Granted May 14, 2024·0 cites·20 claims
- 4569US11525005B2Anti-CD40 antibody, antigen binding fragment thereof and medical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2018·Granted Dec 13, 2022·1 cites·25 claims
- 4669US11304945B2Pharmaceutical composition and method for preparing sameJIANGSU HENGRUI MEDICINE CO·Filed 2018·Granted Apr 19, 2022·1 cites·16 claims
- 4768US2025333494A1Il-5 antibody, antigen binding fragment thereof, and medical application thereforJIANGSU HENGRUI MEDICINE CO·Filed 2025·Application pending·0 cites
- 4867US11059811B2Benzofuran derivative, preparation method thereof and use thereof in medicineJIANGSU HENGRUI MEDICINE CO·Filed 2020·Granted Jul 13, 2021·0 cites·4 claims
- 4967US10759788B2Pharmaceutical uses of pyridine carboxamide derivativesJIANGSU HENGRUI MEDICINE CO·Filed 2019·Granted Sep 1, 2020·0 cites·12 claims
- 5066US12404323B2Antibody capable of binding to thymic stromal lymphopoietin and use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2020·Granted Sep 2, 2025·0 cites·9 claims
Showing the top 50 of 211 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when JIANGSU HENGRUI MEDICINE CO files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →